Sep
21
2022
On demand
Accelerating immuno-oncology innovation using humanized mouse models
Wednesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST
Sponsor
Join us for this very exciting webinar where we discuss some of the most valuable immunology and oncology research tools available to date: humanized mouse models. Learn how these robust, translationally relevant mouse models are rapidly changing preclinical drug development in ways we never thought possible.
- Humanized components of the immune/oncology checkpoint pathways
- Models for bi-specific antibody development
- Next generation immunodeficient mice (NCG) for xenografts and better stem cell engraftment
SPEAKERS
You might also like
Case study: developing an ex vivo gene-modified hematopoietic stem cell treatment for a rare monogenic disease in a novel mouse model
Rafael A. Badell-Grau
29 January
Watch
Accelerating AAV production: optimizing compound identification and process parameters
Keara Sutherland, Jean-Marc Guedon
20 November 2024
Watch
Controlled human infection models in vaccine development: what’s new in 2025?
M B. Laurens, A P. Durbin, M Cavaleri et al.
29 May
in 6
Days
Optimizing for the future: streamlining the production of T cell-based immunotherapies
Paula Lam, Soong Poh Loong
30 October 2024
Watch
Exploring mRNA quality assessment using electrophoretic separation methods
Chateen Krueger
23 April
Watch